HOUSTON (AP) _ Aravive, Inc. (ARAV) on Wednesday reported a loss of $3 million in its second quarter.
On a per-share basis, the Houston-based company said it had a loss of 27 cents.
The biopharmaceutical company posted revenue of $3.1 million in the period.
Aravive shares have increased 95% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.88, a decline of 35% in the last 12 months.